Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients
Clinical trial NCT03618602 · UNKNOWN
Trial details
- NCT number
- NCT03618602
- Sponsor
- Shanghai Theorion Pharmaceutical Co Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2020-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.